These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6219904)

  • 1. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
    Sandler S; Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet implantation normalises hyperglycaemia caused by streptozotocin-induced insulitis. Experiments in mice.
    Andersson A
    Lancet; 1979 Mar; 1(8116):581-4. PubMed ID: 85167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet implantation into diabetic mice with pancreatic insulitis.
    Sandler S; Andersson A
    Acta Pathol Microbiol Scand A; 1981 Mar; 89(2):107-12. PubMed ID: 6455904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.
    Weide LG; Lacy PE
    Diabetes; 1991 Sep; 40(9):1157-62. PubMed ID: 1834505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.
    Leiter EH
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of hyperglycemia by intrasplenic transplantation of 4-week-cultured allogeneic mouse islets.
    Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():55-9. PubMed ID: 6819965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.
    Rossini AA; Appel MC; Williams RM; Like AA
    Diabetes; 1977 Oct; 26(10):916-20. PubMed ID: 143386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of differential survival of syngeneic islets transplanted into hyperglycemic C57BL/6J versus C57BL/KsJ mice.
    Leiter EH
    Transplantation; 1987 Sep; 44(3):401-6. PubMed ID: 2957837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hyperglycaemia, hyperinsulinaemia and genetic background on the fate of intrasplenically implanted mouse islets.
    Andersson A
    Diabetologia; 1983 Sep; 25(3):269-72. PubMed ID: 6416911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by dimethyl urea against hyperglycaemia, but not insulitis, in low-dose streptozotocin-induced diabetes in the mouse.
    Sandler S
    Diabetologia; 1984 May; 26(5):386-8. PubMed ID: 6234194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in streptozotocin-induced diabetic rats.
    Dirice E; Sanlioglu AD; Kahraman S; Ozturk S; Balci MK; Omer A; Griffith TS; Sanlioglu S
    Hum Gene Ther; 2009 Oct; 20(10):1177-89. PubMed ID: 19572802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts.
    Nakano M; Yasunami Y; Maki T; Kodama S; Ikehara Y; Nakamura T; Tanaka M; Ikeda S
    Transplantation; 2000 Jan; 69(2):214-21. PubMed ID: 10670629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
    Sandler S; Andersson A
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitis.
    Mendola J; Wright JR; Lacy PE
    Diabetes; 1989 Mar; 38(3):379-85. PubMed ID: 2521836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal insulin treatment in syngeneic islet transplantation.
    Merino JF; Nacher V; Raurell M; Biarnés M; Soler J; Montanya E
    Cell Transplant; 2000; 9(1):11-8. PubMed ID: 10784061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
    Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates.
    Safley SA; Kenyon NS; Berman DM; Barber GF; Willman M; Duncanson S; Iwakoshi N; Holdcraft R; Gazda L; Thompson P; Badell IR; Sambanis A; Ricordi C; Weber CJ
    Xenotransplantation; 2018 Nov; 25(6):e12450. PubMed ID: 30117193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet graft response to transplantation injury includes upregulation of protective as well as apoptotic genes.
    Rodríguez-Mulero S; Montanya E
    Cell Transplant; 2008; 17(9):1025-34. PubMed ID: 19177839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin treatment of mice recipients preserves beta-cell function in porcine islet transplantation.
    Pakhomov O; Honiger J; Gouin E; Cariolet R; Reach G; Darquy S
    Cell Transplant; 2002; 11(7):721-8. PubMed ID: 12518899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.